Neosaxitoxin

DB12989InvestigationalSmall molecule

Neosaxitoxin is under investigation in clinical trial NCT01786655 (Safety Study of Long-Acting Local Anesthetic).

Mechanism: Pharmacologically active on Sodium channel protein type 9 subunit alpha and Voltage-gated sodium channel alpha subunit
Curator reviewed
Formula / weight: C₁₀H₁₇N₇O₅ · 315.2859 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyPPEKGEBBBBNZKS-HGRQIUPRSA-NSMILES[H][C@@]12N=C(N)N[C@]11N(CCC1(O)O)C(=N)N(O)[C@H]2COC(N)=O

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

818Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Neosaxitoxin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.